ArticleGE Portuguese journal of gastroenterology2025
Gastric Peroral Endoscopic Myotomy for Refractory Gastroparesis with a Median Follow-Up of 10 Months: An Indian Experience.
Article in GE Portuguese journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gastric peroral endoscopic myotomy has shown promising results for refractory gastroparesis. We share our Indian experience of gastric peroral endoscopic myotomy performed over the last 5 years. Methods: This is a retrospective study of prospectively maintained data of patients who underwent gastric peroral endoscopic myotomy for refractory gastroparesis at our center. The primary outcome was to assess the clinical success at 3 months measured by ≥50% reduction of gastroparesis cardinal symptom index score from the baseline. The secondary outcomes were to assess the technical success, change in percentage retention at 4 h in gastric emptying scintigraphy at 6 months, change in gastroparesis cardinal symptom index score, Patient Assessment of Upper Gastrointestinal Disorders-Quality of Life score at 1, 6 months and 1 year, respectively, and adverse event rate graded by AGREE classification. Results: Between 2019 and 2024, 16 patients underwent gastric peroral endoscopic myotomy in our unit. The median (IQR) age was 40 (30.5, 48.75), and 10 were females (62.5%). The most common etiology was idiopathic (11/16, 68.8%). The clinical success at 3 months was 72.4% (8/11), which was sustained at 6 months and 1 year of follow-up to 71.7% (5/7). The technical success was 100%. There was a significant reduction in gastroparesis cardinal symptom index score, Patient Assessment of Upper Gastrointestinal Disorders-Quality of Life score at 1, 3, 6 months and 1 year. Similarly, there was a significant reduction in the percentage retention at 4 h in gastric emptying scintigraphy at 6 months. One patient needed intraoperative needle aspiration of the capnoperitoneum while another had hematemesis after discharge, which was managed conservatively. Conclusion: Our first Indian experience of gastric peroral endoscopic myotomy for refractory gastroparesis shows similar outcomes compared to global literature with gastric peroral endoscopic myotomy emerging as a preferred modality in these subsets of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.